Session IV. Implications from Clinical Finding of GI Cancers (Oral presentation)
1 CA19-9 Is an Independent Prognostic factor for Locally Advanced Pancreatic Cancer Patients Treated with Chemoradiotherapy Á¤¹®Àç(¿¬¼¼ÀÇ´ë)
2 FOLFOX4 as a Rescue Chemotherapy in Gemcitabine Based Chemotherapy Refractory Pancreatic Cancer ÀåÈñ¿ø(¿¬¼¼ÀÇ´ë)
3 ¼ö¼úÀû ÀýÁ¦°¡ ºÒ°¡´ÉÇÑ ÃéÀå¾Ï¿¡ ´ëÇÑ Ç׾Ͽä¹ý ½ÃÇà ÈÄ 2³â ÀÌ»ó »ýÁ¸ÇÑ È¯Àڵ鿡 ´ëÇÑ ÀÓ»óÀû °íÂû ¾Èµ¿¿ø(¼­¿ïÀÇ´ë)
4 Clinical Usefulness of CD44 as a Chemotherapeutic Marker in Pancreatobiliary Cancer ¹Ú¼¼¹Ì(¿¬¼¼ÀÇ´ë)